Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2774 studies found for:    "Antifungal Agents"
Show Display Options
Rank Status Study
1 Active, not recruiting Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
Condition: Systemic Fungal Infections
Interventions: Drug: Parenteral micafungin application;   Drug: Other parenteral antifungal drugs
2 Completed Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: Anti-fungal agent (Clotrimazole) loaded microcapsules;   Drug: Placebo
3 Completed Antifungal Use in Oncohematological Neutropenic Patients
Condition: Invader Fungal Infection
Intervention: Drug: Antifungal drug. VORICONAZOL. (VFEND®)
4 Recruiting PEACE: Pediatric Antifungal Comparative Effectiveness
Condition: Pediatric Invasive Candidiasis
Intervention: Drug: Observational antifungal therapy
5 Unknown  Antifungal Locks to Treat Fungal-Related Central Line Infections
Condition: Central Line Fungal Infections
Intervention: Drug: amphotericin B liposomal (Ambisome)
6 Terminated Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients
Conditions: Invasive Fungal Infections;   Invasive Aspergillosis;   Invasive Fusariosis
Intervention: Drug: caspofungin as preemptive antifungal therapy
7 Terminated Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment
Conditions: Ventilator Associated Pneumonia;   Respiratory Tract Infection
Interventions: Other: Normal Saline;   Drug: anidulafungin
8 Completed Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian Centers
Condition: Fungal Infection
Intervention:
9 Recruiting Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)
Conditions: Fungal Infection;   Critical Illness
Intervention: Other: Biomarker group
10 Unknown  Efficacy and Safety of RV4104A Ointment in Onychomycosis
Condition: Onychomycosis
Intervention: Drug: Keratolytic/Antifungal
11 Recruiting Empirical Versus Preemptive Antifungal Therapy
Conditions: Fungal Infection;   Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: caspofungin acetate
12 Completed
Has Results
β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients
Condition: Invasive Candidiasis
Interventions: Drug: Preemptive Therapy with Anidulafungin;   Drug: Empiric antifungal therapy based on physician discretion.
13 Terminated Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia
Conditions: Malignant Hemopathy;   Duration of Neutropenia Following Chemotherapy > 10 Days
Intervention: Drug: Amphotericin B
14 Completed A Study of Empirical Antifungal Therapy With Itraconazole
Condition: Neutropenia
Intervention: Drug: Itraconazole
15 Completed Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs
Conditions: HIV Infections;   Histoplasmosis
Intervention:
16 Completed Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Itraconazole;   Drug: Flucytosine;   Drug: Fluconazole;   Drug: Amphotericin B;   Drug: Interferon gamma-1b
17 Completed PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-Cell Transplantation and Acute Leukaemia
Condition: Leukemia
Intervention: Drug: Ambisome
18 Not yet recruiting Serial Therapeutic and Antifungal Monitoring Protocol
Condition: Candidemia
Intervention:
19 Completed PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation
Condition: Fungus Diseases
Intervention: Drug: AmBisome
20 Unknown  Antifungal Prophylaxis in Pediatric Acute Leukemia
Condition: Pediatric Acute Leukemia Induction
Intervention: Drug: ORAL VORICONAZOLE and IV Amphotericin B

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years